Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021

dc.contributor.authorGuler, Ozan Cem
dc.contributor.authorIsci, Oguzhan
dc.contributor.authorOnal, Cem
dc.contributor.pubmedID35307322en_US
dc.date.accessioned2022-12-23T12:14:53Z
dc.date.available2022-12-23T12:14:53Z
dc.date.issued2022
dc.identifier.eissn2588-9311en_US
dc.identifier.endpage478en_US
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85135500414en_US
dc.identifier.startpage477en_US
dc.identifier.urihttp://hdl.handle.net/11727/8435
dc.identifier.volume5en_US
dc.identifier.wos000843280400017en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.euo.2022.03.002en_US
dc.relation.journalEUROPEAN UROLOGY ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleRe: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021en_US
dc.typeLetteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: